Physiopathology of Cushing's disease.
D000236:Adenoma / Q000032:analysis; D001696:Biomechanical Phenomena; D001971:Bromocriptine / Q000627:therapeutic use; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D003533:Cyproheptadine / Q000627:therapeutic use; D004195:Disease Models, Animal; D005544:Forecasting; D005938:Glucocorticoids / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors / Q000502:physiology; D010455:Peptides / Q000032:analysis / Q000502:physiology; D010902:Pituitary Gland / Q000166:cytology / Q000378:metabolism / Q000473:pathology / Q000528:radiation effects / Q000601:surgery; D010908:Pituitary Hormones, Anterior / Q000502:physiology; D010911:Pituitary Neoplasms / Q000032:analysis; D011333:Pro-Opiomelanocortin; D011498:Protein Precursors / Q000502:physiology
D005938:Glucocorticoids; D018377:Neurotransmitter Agents; D010455:Peptides; D010908:Pituitary Hormones, Anterior; D011498:Protein Precursors; D003533:Cyproheptadine; D001971:Bromocriptine; D011333:Pro-Opiomelanocortin